Atara Biotherapeutics Announces Third Quarter 2022 Financial Results and Operational Progress

Go back to Atara Biotherapeutics Announces Third Quarter 2022 Financial Results and Operational Progress
(NASDAQ: ATRA) Delayed: 9.02 --0 (-0%)
Previous Close $9.02    52 Week High $40.80 
Open $9.02    52 Week Low $12.45 
Day High $9.02    P/E N/A 
Day Low $9.02    EPS $0.00 
Volume